Adapt Or Die: Sanofi CSO On R&D Challenges Within Unstable Industry

 
• By Lucie Ellis-Taitt
  
Gary Nabel
Gary Nabel, SVP and chief scientific officer at Sanofi • Source: Sanofi
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip